Welcome To

InflaRx - controlling inflammation


InflaRx develops new first-in-class therapeutics

in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.

InflaRx's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases.

InflaRx News